Amir Lass is an accomplished Medical Director and Owner of Haipharm since January 2014, specializing in pharmaceutical medical consulting for medical affairs and clinical development across various therapeutic areas. Amir serves as a Non Executive Director at Irody, a digital health technology company, and has been an Appraiser with the Faculty of Pharmaceutical Medicine since 2017. Previously, Amir held the position of Vice President of Medical Affairs for Europe at Teva Pharmaceuticals, overseeing medical activities across 30 countries. Earlier professional experiences include leadership roles at Serono Pharma and Bourn Hall Fertility Clinic, along with clinical training and research positions in obstetrics, gynecology, and reproductive health. Amir holds an MD and B.Med.Sc from The Hebrew University of Jerusalem, an MBA from the University of Westminster, and an MA in Modern Israeli Studies from UCL.